# Effect of Single Doses of 10 mg NRL001 Applied as a Suppository to the Anal Canal or Rectum

> **NCT00893607** · PHASE1 · COMPLETED · sponsor: **Norgine** · enrollment: 24 (actual)

## Conditions studied

- Fecal Incontinence

## Interventions

- **DRUG:** NRL001

## Key facts

- **NCT ID:** NCT00893607
- **Lead sponsor:** Norgine
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2007-08
- **Final completion:** 2007-12
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2009-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00893607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00893607, "Effect of Single Doses of 10 mg NRL001 Applied as a Suppository to the Anal Canal or Rectum". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00893607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*